CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Multicentric, Open-Label Trial to Investigate the Benefit of Adding Fasten Onco Digital Therapy Integrating a Fasting Mimicking Diet During Neoadjuvant Treatment to Standard of Care, Compared to Standard of Care Alone, in Women (Aged 18 Years or Older), With Early-Stage II/III Triple-Negative Breast Cancer (FAST-01)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07884721
Title field or adapter rule: {'original_value': 'A Randomized, Multicentric, Open-Label Trial to Investigate the Benefit of Adding Fasten Onco Digital Therapy Integrating a Fasting Mimicking Diet During Neoadjuvant Treatment to Standard of Care, Compared to Standard of Care Alone, in Women (Aged 18 Years or Older), With Early-Stage II/III Triple-Negative Breast Cancer (FAST-01)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:30.447049+00:00
Published At: 2026-10-21T00:00:00+00:00
Record Updated At: 2026-10-21
Source Retrieved At: 2026-10-31T22:18:22.973355+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["Triple-Negative Breast Cancer (TNBC)"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-21", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT07884721"
protocolSection.identificationModule.officialTitle: "A Randomized, Multicentric, Open-Label Trial to Investigate the Benefit of Adding Fasten Onco Digital Therapy Integrating a Fasting Mimicking Diet During Neoadjuvant Treatment to Standard of Care, Compared to Standard of Care Alone, in Women (Aged 18 Years or Older), With Early-Stage II/III Triple-Negative Breast Cancer (FAST-01)"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

{'armGroupLabels': ['FASTEN Group'], 'description': "Fasten Onco is a digital medical device designed to support the implementation of a fasting-mimicking diet (FMD) during neoadjuvant treatment. The device provides a personalized nutritional program synchronized with the participant's treatment schedule, together with educational content, reminders, and guidance to support adherence. The program is prescribed and configured by a healthcare professional and is used under medical supervision.", 'name': 'Fasten Onco', 'type': 'DEVICE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Standard of Care Group'], 'description': 'Standard neoadjuvant treatment for stage II/III triple-negative breast cancer according to the standard of care at each participating center. Treatment may include paclitaxel, carboplatin, epirubicin or doxorubicin, cyclophosphamide, and pembrolizumab, used within their approved indications. Standard neoadjuvant treatment is administered in both study groups.', 'name': 'Standard Neoadjuvant Treatment', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.